Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Tao Capital Management LP

Q2 2023 · 13F-HR

Tao Capital Management LPholdings as filed

Filed 2023-08-14 · accession 0001912008-23-000004

$136,566
Reported value
14
Positions
2023-06-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
90353T100UBERUber Technologies, Inc.$55,46840.6%1,284,851CommonSOLE
88160R101TSLATesla, Inc.$22,57816.5%86,250CommonSOLE
558868105MDGLMadrigal Pharmaceuticals, Inc.$17,93913.1%77,657CommonSOLE
90184D100TWSTTwist Bioscience Corporation$16,95812.4%828,815CommonSOLE
448579102HHyatt Hotels Corporation$8,0215.87%70,000CommonSOLE
68989M103Ouster, Inc.$5,5604.07%1,125,315CommonSOLE
65443P102MASS908 Devices Inc.$3,9042.86%568,981CommonSOLE
082490103Benson Hill, Inc.$2,3081.69%1,774,681CommonSOLE
93403J106WRBYWarby Parker Inc.$1,5721.15%134,473CommonSOLE
83542D102Sonder Holdings Inc.$8510.62%1,603,797CommonSOLE
39536G105GreenLight Biosciences Holdings, PBC$8020.59%2,671,664CommonSOLE
37611X100DNA4EURGinkgo Bioworks Holdings, Inc.$4230.31%227,354CommonSOLE
24823R105DNLIDenali Therapeutics Inc.$1080.08%3,651CommonSOLE
09077J107Bird Global, Inc.$740.05%36,200CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.